Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets animal health products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics for treating infestations of parasitic intestinal worms; anti-bloat treatment products used in cattle to control bloat in animals grazing on legume, or wheat-pasture; and medicated feed additives and other related products. The company’s animal health products also comprise nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily in the poultry and swine industries. In addition, it manufactures and markets approximately formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds.

Teaneck, US
Size (employees)
1,300 (est)+9%
Phibro Animal Health Corporation was founded in 2003 and is headquartered in Teaneck, US

Phibro Animal Health Corporation Office Locations

Phibro Animal Health Corporation has an office in Teaneck
Teaneck, US (HQ)
500 Glenpointe Centre W

Phibro Animal Health Corporation Data and Metrics

Phibro Animal Health Corporation Financial Metrics

Phibro Animal Health Corporation's revenue was reported to be $751.5 m in FY, 2016 which is a 0% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

751.5 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

239 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

82.7 m

EBIT (FY, 2016)

85.7 m

Market capitalization (26-May-2017)

1.4 b

Closing share price (26-May-2017)


Cash (30-Jun-2016)

33.6 m


1.6 b
Phibro Animal Health Corporation's current market capitalization is $1.4 b.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016


691.9 m748.6 m751.5 m

Revenue growth, %


Cost of goods sold

484.1 m512.2 m512.5 m

Gross profit

207.8 m236.4 m239 m

Gross profit Margin, %


General and administrative expense

144 m148.7 m153.3 m

Operating expense total

144 m148.7 m153.3 m


63.8 m87.7 m85.7 m

EBIT margin, %


Interest expense

29.9 m14.6 m16.6 m

Pre tax profit

6.3 m78.8 m76.8 m

Income tax expense

9.4 m18.5 m(6 m)

Net Income

(3.1 m)60.3 m82.7 m
Numbers are in $, USDFY, 2014FY, 2015FY, 2016


11.8 m29.2 m33.6 m

Accounts Receivable

113.9 m111.1 m123.8 m


30.4 m23.6 m5.2 m

Current Assets

299.3 m313.7 m342.8 m


109.2 m104.4 m127.3 m


21.1 m

Total Assets

472.3 m493.3 m610.4 m

Accounts Payable

59.6 m63.1 m60.2 m

Total Debt

289.4 m286.5 m283.7 m

Current Liabilities

112.4 m111.3 m108.7 m

Additional Paid-in Capital

132.5 m118.2 m118.3 m

Retained Earnings

(97.2 m)(37 m)34 m

Total Equity

15.1 m29.6 m90.5 m

Debt to Equity Ratio

19.1 x9.7 x3.1 x

Debt to Assets Ratio

0.6 x0.6 x0.5 x

Financial Leverage

31.2 x16.7 x6.7 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

(3.1 m)60.3 m82.7 m

Depreciation and Amortization

21.5 m21.6 m23.5 m

Accounts Receivable

(14.7 m)(1.9 m)(13.1 m)


(31 k)7.4 m(6.9 m)

Accounts Payable

1.7 m4.8 m(3.2 m)

Cash From Operating Activities

(712 k)68.7 m37.2 m

Capital Expenditures

(19.8 m)(20.1 m)(36.4 m)

Dividends Paid

(25 m)(15.6 m)(15.7 m)

Cash From Financing Activities

4.8 m(15.4 m)50.4 m

Interest Paid

45.4 m12.9 m14.2 m

Free Cash Flow

(20.6 m)48.6 m866 k
Y, 2016


18.9 x


43.5 x


1.9 k x


3.1 x


0.5 x

Financial Leverage

6.7 x

Phibro Animal Health Corporation Operating Metrics

FY, 2015FY, 2016


2.9 k3 k

Phibro Animal Health Corporation Market Value History

Phibro Animal Health Corporation Company Life and Culture

You may also be interested in